Design Therapeutics, Inc. files to offer $300 million in securities, aiming to enhance its financial position and support its innovative therapies.
| Name | Design Therapeutics, Inc. |
|---|---|
| CIK | 0001807120 |
| Tickers | DSGN |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 823929248 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 858-293-4900 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Design Therapeutics, Inc. files to offer $300 million in securities, aiming to enhance its financial position and support its innovative therapies.
Design Therapeutics increases its common stock offering to $200 million, reflecting confidence in the pharmaceutical sector and strong market demand.
Design Therapeutics, Inc. announces its financial results for Q3 2026, highlighting its performance in the pharmaceutical preparations sector.
270 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000938206-26-000062 | 005-92462 | 261556599 | 34 | 7651 | |||
| 2026-11-12 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003535 | 333-299827 | 261548839 | 33 | 1766 | ||
| 2026-11-04 | S-3 | S-3 | 0001193125-26-447545 | 333-299827 | 261523512 | 33 | 556714 | 1 | 1 | |
| 2026-11-04 | 424B5 | 424B5 | 0001193125-26-447373 | 333-287043 | 261522788 | 33 | 81477 | |||
| 2026-11-04 | 10-Q | 10-Q | 0001193125-26-447258 | 001-40288 | 261522326 | 34 | 8948006 | 1 | 1 | |
| 2026-11-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-447235 | 001-40288 | 261522221 | 34 | 493397 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005487 | 005-92462 | 261281401 | 34 | 12272 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005202 | 005-92462 | 261276426 | 34 | 15153 | |||
| 2026-08-03 | 10-Q | 10-Q | 0001193125-26-329579 | 001-40288 | 261230524 | 34 | 8512686 | 1 | 1 | |
| 2026-08-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-329570 | 001-40288 | 261230518 | 34 | 489252 | 1 | 1 |
| 2026-06-11 | 4 | 4 | 0001193125-26-267732 | 5452 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_040611.xml | 0001478916-26-000009 | 5667 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_040609.xml | 0001579826-26-000002 | 5702 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_040607.xml | 0001754129-26-000006 | 5712 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_040613.xml | 0001559570-26-000008 | 5685 | ||||||
| 2026-06-11 | 4 | xslF345X06/form4-06112026_040606.xml | 0001751873-26-000002 | 5785 | ||||||
| 2026-06-11 | 8-K | 8-K | 5.07 | 0001193125-26-267485 | 001-40288 | 261083005 | 34 | 169959 | 1 | 1 |
| 2026-06-09 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003921 | 005-92462 | 261076969 | 34 | 17673 | |||
| 2026-05-18 | 8-K | 8-K | 8.01 | 0001193125-26-227875 | 001-40288 | 26990769 | 34 | 154384 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003492 | 005-92462 | 26988270 | 34 | 12314 | |||
| 2026-04-28 | 10-Q | 10-Q | 0001193125-26-187063 | 001-40288 | 26907927 | 34 | 7689991 | 1 | 1 | |
| 2026-04-28 | 8-K | 8-K | 2.02,7.01 | 0001193125-26-187012 | 001-40288 | 26907782 | 34 | 75951507 | 1 | 1 |
| 2026-04-23 | DEFA14A | DEFA14A | 0001193125-26-173689 | 001-40288 | 26888687 | 34 | 4137314 | |||
| 2026-04-23 | DEF 14A | DEF 14A | 0001193125-26-173678 | 001-40288 | 26888640 | 34 | 9068371 | 1 | 1 | |
| 2026-04-23 | ARS | ARS | 0001193125-26-173640 | 001-40288 | 26888493 | 34 | 4207244 | |||
| 2026-04-01 | 4 | xslF345X06/form4-04012026_080415.xml | 0001559570-26-000006 | 7812 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080440.xml | 0001559570-26-000004 | 8152 | ||||||
| 2026-04-01 | 8-K | 8-K | 5.02 | 0001193125-26-137861 | 001-40288 | 26828067 | 34 | 156142 | 1 | 1 |
| 2026-03-11 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001072613-26-000257 | 005-92462 | 26745427 | 34 | 125234 | |||
| 2026-03-09 | S-8 | S-8 | 0001193125-26-098540 | 333-294144 | 26735176 | 33 | 344323 | 1 | 1 | |
| 2026-03-09 | 10-K | 10-K | 0001193125-26-098491 | 001-40288 | 26734991 | 34 | 26142252 | 1 | 1 | |
| 2026-03-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-098474 | 001-40288 | 26734915 | 34 | 489400 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001131 | 005-92462 | 26642051 | 34 | 12313 | |||
| 2026-01-30 | 8-K | 8-K | 5.02 | 0001193125-26-031772 | 001-40288 | 26583353 | 34 | 140088 | 1 | 1 |
| 2026-01-05 | 4 | xslF345X05/form4-01052026_090112.xml | 0001674703-26-000002 | 5702 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01052026_090157.xml | 0001848377-26-000002 | 5702 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01052026_090130.xml | 0001883722-26-000002 | 5703 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01052026_090117.xml | 0001754129-26-000002 | 5438 | ||||||
| 2026-01-05 | 4 | xslF345X05/form4-01052026_090147.xml | 0001580787-26-000002 | 5676 | ||||||
| 2025-12-11 | 4 | xslF345X05/form4-12112025_041203.xml | 0001580787-25-000006 | 8184 | ||||||
| 2025-11-18 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000935836-25-000710 | 005-92462 | 251496145 | 34 | 28949 | |||
| 2025-11-18 | 144 | xsl144X01/primary_doc.xml | 0001178937-25-000065 | 001-40288 | 251495134 | 33 | 5690 | |||
| 2025-11-14 | 144 | xsl144X01/primary_doc.xml | 0001178937-25-000060 | 001-40288 | 251486644 | 33 | 5090 | |||
| 2025-11-12 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000935836-25-000657 | 005-92462 | 251474169 | 34 | 27785 | |||
| 2025-11-07 | 144 | xsl144X01/primary_doc.xml | 0001178937-25-000059 | 001-40288 | 251463694 | 33 | 5093 | |||
| 2025-11-05 | 10-Q | 10-Q | 0001193125-25-266970 | 001-40288 | 251454218 | 34 | 8725592 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-266933 | 001-40288 | 251454054 | 34 | 488835 | 1 | 1 |
| 2025-09-10 | 4 | xslF345X05/form4-09102025_090913.xml | 0001415889-25-024109 | 7710 | ||||||
| 2025-09-10 | 3 | xslF345X02/form3-09102025_090926.xml | 0001415889-25-024108 | 8074 | ||||||
| 2025-09-10 | 8-K | 8-K | 5.02 | 0001807120-25-000004 | 001-40288 | 251305887 | 34 | 157872 | 1 | 1 |
| 2025-08-28 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003881 | 005-92462 | 251273350 | 34 | 18081 | |||
| 2025-08-14 | 4 | xslF345X05/form4-08142025_040805.xml | 0001415889-25-021842 | 7425 | ||||||
| 2025-08-13 | 144 | xsl144X01/primary_doc.xml | 0001178937-25-000028 | 001-40288 | 251213710 | 33 | 4516 | |||
| 2025-08-13 | 144 | xsl144X01/primary_doc.xml | 0001178937-25-000027 | 001-40288 | 251213708 | 33 | 4534 | |||
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105062 | 001-40288 | 251194346 | 34 | 8818845 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,7.01 | 0000950170-25-105008 | 001-40288 | 251194003 | 34 | 24225907 | 1 | 1 |
| 2025-06-12 | 4 | 4 | 0000950170-25-085506 | 5289 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4-06122025_040608.xml | 0001415889-25-016957 | 5550 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4-06122025_040614.xml | 0001415889-25-016959 | 5561 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4-06122025_040606.xml | 0001415889-25-016956 | 5648 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4-06122025_040611.xml | 0001415889-25-016958 | 5530 | ||||||
| 2025-06-12 | 4 | xslF345X05/form4-06122025_040604.xml | 0001415889-25-016955 | 5565 | ||||||
| 2025-06-12 | 8-K | 8-K | 5.07 | 0000950170-25-085380 | 001-40288 | 251042773 | 34 | 175066 | 1 | 1 |
| 2025-05-23 | 4 | xslF345X05/form4-05232025_080531.xml | 0001415889-25-014477 | 5543 | ||||||
| 2025-05-23 | 3 | xslF345X02/form3-05232025_080546.xml | 0001415889-25-014473 | 8041 | ||||||
| 2025-05-16 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001643 | 333-287043 | 25961391 | 33 | 1765 | ||
| 2025-05-14 | CORRESP | filename1.htm | 0001193125-25-119753 | 7408 | ||||||
| 2025-05-13 | UPLOAD | filename1.pdf | 0000000000-25-005100 | 333-287043 | 40132 | |||||
| 2025-05-07 | S-3 | S-3 | 0001193125-25-114986 | 333-287043 | 25922442 | 33 | 1279188 | |||
| 2025-05-07 | 10-Q | 10-Q | 0000950170-25-065643 | 001-40288 | 25921350 | 34 | 8018324 | 1 | 1 | |
| 2025-05-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-065613 | 001-40288 | 25921190 | 34 | 466094 | 1 | 1 |
| 2025-04-30 | DEFR14A | DEFR14A | 0000950170-25-061037 | 001-40288 | 25895027 | 34 | 5189317 | 1 | 1 | |
| 2025-04-24 | ARS | ARS | 0000950170-25-058051 | 001-40288 | 25867482 | 34 | 22582950 | |||
| 2025-04-24 | DEFA14A | DEFA14A | 0000950170-25-058022 | 001-40288 | 25867370 | 34 | 1102937 | |||
| 2025-04-24 | DEF 14A | DEF 14A | 0000950170-25-058008 | 001-40288 | 25867279 | 34 | 3261176 | |||
| 2025-03-10 | S-8 | S-8 | 0000950170-25-035913 | 333-285660 | 25722149 | 33 | 359624 | 1 | 1 | |
| 2025-03-10 | 10-K | 10-K | 0000950170-25-035910 | 001-40288 | 25722137 | 34 | 29095904 | 1 | 1 | |
| 2025-03-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-035909 | 001-40288 | 25722132 | 34 | 478157 | 1 | 1 |
| 2025-02-07 | 3 | xslF345X02/form3-02072025_090223.xml | 0001415889-25-003349 | 8989 | ||||||
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-003348 | 005-92462 | 25601948 | 34 | 9435 | |||
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-003347 | 005-92462 | 25601927 | 34 | 9443 | |||
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-004612 | 001-40288 | 25525067 | 34 | 7463762 | 1 | 1 |
| 2025-01-06 | 4 | xslF345X05/form4-01062025_070132.xml | 0001415889-25-000880 | 5475 | ||||||
| 2025-01-06 | 4 | xslF345X05/form4-01062025_070130.xml | 0001415889-25-000879 | 5710 | ||||||
| 2025-01-06 | 4 | xslF345X05/form4-01062025_070127.xml | 0001415889-25-000878 | 5683 | ||||||
| 2025-01-06 | 4 | xslF345X05/form4-01062025_070125.xml | 0001415889-25-000877 | 5709 | ||||||
| 2024-12-19 | 4 | xslF345X05/form4-12192024_061201.xml | 0001415889-24-029913 | 4634 | ||||||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123349 | 001-40288 | 241435865 | 34 | 7429292 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-123289 | 001-40288 | 241435556 | 34 | 448770 | 1 | 1 |
| 2024-08-13 | SC 13D/A | dsgn13d.htm | 0000935836-24-000514 | 005-92462 | 241203600 | 34 | 74633 | |||
| 2024-08-12 | 4 | xslF345X05/form4-08122024_080818.xml | 0001415889-24-021086 | 7508 | ||||||
| 2024-08-09 | 144 | xsl144X01/primary_doc.xml | 0001178937-24-000042 | 001-40288 | 241193112 | 33 | 4486 | |||
| 2024-08-05 | 10-Q | 10-Q | 0000950170-24-090337 | 001-40288 | 241173173 | 34 | 7262929 | 1 | 1 | |
| 2024-08-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-090332 | 001-40288 | 241173144 | 34 | 446706 | 1 | 1 |
| 2024-06-17 | 4 | 4 | 0000950170-24-074363 | 5296 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_050620.xml | 0001415889-24-017241 | 5568 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_050616.xml | 0001415889-24-017239 | 5572 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_050618.xml | 0001415889-24-017240 | 5537 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_050614.xml | 0001415889-24-017238 | 5655 | ||||||
| 2024-06-17 | 4 | xslF345X05/form4-06172024_050611.xml | 0001415889-24-017237 | 5557 | ||||||
| 2024-06-17 | 8-K | 8-K | 5.07 | 0000950170-24-074243 | 001-40288 | 241048345 | 34 | 170150 | 1 | 1 |
| 2024-05-08 | 10-Q | 10-Q | 0000950170-24-055788 | 001-40288 | 24926738 | 34 | 6741322 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-055645 | 001-40288 | 24926058 | 34 | 425187 | 1 | 1 |
| 2024-04-25 | ARS | ARS | 0000950170-24-048411 | 001-40288 | 24876999 | 34 | 15049710 | |||
| 2024-04-25 | DEFA14A | DEFA14A | 0000950170-24-048399 | 001-40288 | 24876932 | 34 | 290209 | |||
| 2024-04-25 | DEF 14A | DEF 14A | 0000950170-24-048385 | 001-40288 | 24876874 | 34 | 1464849 | |||
| 2024-03-25 | 4 | xslF345X05/form4-03252024_110321.xml | 0001415889-24-009063 | 7342 | ||||||
| 2024-03-25 | 4 | xslF345X05/form4-03252024_110307.xml | 0001415889-24-009062 | 4714 | ||||||
| 2024-03-20 | 3 | xslF345X02/form3-03202024_110345.xml | 0001415889-24-008788 | 14362 | ||||||
| 2024-03-19 | S-8 | S-8 | 0000950170-24-033525 | 333-278064 | 24763687 | 33 | 154022 | |||
| 2024-03-19 | 10-K | 10-K | 0000950170-24-033492 | 001-40288 | 24763484 | 34 | 34937688 | 1 | 1 | |
| 2024-03-19 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-033475 | 001-40288 | 24763345 | 34 | 321291 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023960 | 005-92462 | 24640017 | 34 | 137868 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 3 | 0000929638-24-000641 | 005-92462 | 24636486 | 34 | 148104 | |||
| 2024-01-23 | SC 13G/A | Design_Th_Inc.txt | 0000093751-24-000097 | 005-92462 | 24550880 | 34 | 8421 | |||
| 2024-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-001042 | 5760 | ||||||
| 2024-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-001039 | 5759 | ||||||
| 2023-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-057552 | 5441 | ||||||
| 2023-12-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-057548 | 5441 | ||||||
| 2023-11-14 | SC 13G/A | SC 13G/A | 0001104659-23-118212 | 005-92462 | 231407673 | 34 | 84811 | |||
| 2023-11-13 | 10-Q | 10-Q | 0000950170-23-062958 | 001-40288 | 231398898 | 34 | 8870329 | 1 | 1 | |
| 2023-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-062937 | 001-40288 | 231398751 | 34 | 366977 | 1 | 1 |
| 2023-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-051175 | 4991 | ||||||
| 2023-09-07 | SC 13G/A | us25056l1035_090623.txt | 0001306550-23-009874 | 005-92462 | 231241216 | 34 | 12471 | |||
| 2023-09-06 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-048441 | 10365 | ||||||
| 2023-09-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-048222 | 10818 | ||||||
| 2023-08-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-047774 | 5064 | ||||||
| 2023-08-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-047773 | 10086 | ||||||
| 2023-08-25 | 8-K | 8-K | 5.02 | 0001193125-23-221586 | 001-40288 | 231209153 | 34 | 153413 | 1 | 1 |
| 2023-08-14 | 10-Q | 10-Q | 0000950170-23-042411 | 001-40288 | 231170208 | 34 | 8871878 | 1 | 1 | |
| 2023-08-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-042392 | 001-40288 | 231169972 | 34 | 404625 | 1 | 1 |
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033847 | 5444 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033787 | 5481 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033784 | 5461 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033785 | 5469 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033782 | 5492 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033781 | 5579 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033778 | 5496 | ||||||
| 2023-06-01 | 8-K | 8-K | 5.07 | 0001193125-23-159009 | 001-40288 | 23985347 | 34 | 156885 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019714 | 001-40288 | 23902359 | 34 | 7674056 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-019682 | 001-40288 | 23902160 | 34 | 372838 | 1 | 1 |
| 2023-04-13 | ARS | ARS | 0000950170-23-012726 | 001-40288 | 23818841 | 34 | 3100498 | |||
| 2023-04-13 | DEFA14A | DEFA14A | 0000950170-23-012725 | 001-40288 | 23818808 | 34 | 2772440 | |||
| 2023-04-13 | DEF 14A | DEF 14A | 0000950170-23-012723 | 001-40288 | 23818795 | 34 | 1285748 | |||
| 2023-04-03 | SC 13G | DESIGN THERAPEUTICS, INC. | 0001104659-23-040937 | 005-92462 | 23793590 | 34 | 138319 | |||
| 2023-03-14 | S-8 | S-8 | 0000950170-23-007877 | 333-270527 | 23731383 | 33 | 222895 | |||
| 2023-03-14 | 10-K | 10-K | 0000950170-23-007869 | 001-40288 | 23731046 | 34 | 13165769 | 1 | 1 | |
| 2023-03-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-007864 | 001-40288 | 23730782 | 34 | 408270 | 1 | 1 |
| 2023-02-14 | SC 13G/A | schedule13g.htm | 0000929638-23-000569 | 005-92462 | 23627789 | 34 | 148331 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020770 | 005-92462 | 23622717 | 34 | 137840 | |||
| 2023-02-08 | SC 13G | Design_Therapeutics_Inc.txt | 0000093751-23-000361 | 005-92462 | 23598205 | 34 | 8347 | |||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006927 | 5644 | ||||||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006921 | 5646 | ||||||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006917 | 5612 | ||||||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-006910 | 5606 | ||||||
| 2023-02-03 | SC 13G | us25056l1035_020323.txt | 0001306550-23-007105 | 005-92462 | 23584717 | 34 | 13200 | |||
| 2022-12-22 | SC 13D/A | SC 13D/A | 0001193125-22-311061 | 005-92462 | 221482265 | 34 | 196798 | |||
| 2022-12-22 | SC 13G | SC 13G | 0001104659-22-129507 | 005-92462 | 221481960 | 34 | 132345 | |||
| 2022-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-062349 | 6850 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062227 | 24561 | ||||||
| 2022-12-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-062226 | 28062 | ||||||
| 2022-12-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-060738 | 4961 | ||||||
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021885 | 001-40288 | 221358237 | 34 | 8873033 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-021862 | 001-40288 | 221358051 | 34 | 415955 | 1 | 1 |
| 2022-10-13 | SC 13G | SC 13G | 0001104659-22-108513 | 005-92462 | 221309341 | 34 | 83414 | |||
| 2022-08-08 | 10-Q | 10-Q | 0000950170-22-015533 | 001-40288 | 221144511 | 34 | 8391528 | 1 | 1 | |
| 2022-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-015520 | 001-40288 | 221144407 | 34 | 399761 | 1 | 1 |
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037525 | 5440 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037524 | 5467 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037517 | 5432 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037514 | 5463 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037511 | 5432 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037509 | 5452 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037503 | 5550 | ||||||
| 2022-06-16 | 8-K | 8-K | 5.07 | 0000950170-22-011751 | 001-40288 | 221020891 | 34 | 196913 | 1 | 1 |
| 2022-05-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-05-09 17:00:00 | 9999999995-22-001375 | 333-264521 | 22907154 | 33 | 1723 | ||
| 2022-05-09 | 10-Q | 10-Q | 0000950170-22-008500 | 001-40288 | 22905117 | 34 | 7395082 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008486 | 001-40288 | 22904986 | 34 | 354129 | 1 | 1 |
| 2022-05-05 | CORRESP | filename1.htm | 0001193125-22-142131 | 7950 | ||||||
| 2022-05-02 | CORRESP | filename1.htm | 0001193125-22-136205 | 7421 | ||||||
| 2022-04-29 | UPLOAD | filename1.pdf | 0000000000-22-004681 | 40219 | ||||||
| 2022-04-27 | S-3 | S-3 | 0001193125-22-123965 | 333-264521 | 22861073 | 33 | 1320205 | |||
| 2022-04-27 | DEFA14A | DEFA14A | 0001193125-22-123696 | 001-40288 | 22860047 | 34 | 37953 | |||
| 2022-04-27 | DEF 14A | DEF 14A | 0001193125-22-123683 | 001-40288 | 22859993 | 34 | 521824 | |||
| 2022-03-31 | SC 13D | dsgn13d.htm | 0000935836-22-000298 | 005-92462 | 22792903 | 34 | 56575 | |||
| 2022-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-020638 | 7318 | ||||||
| 2022-03-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-020637 | 12873 | ||||||
| 2022-03-22 | 8-K | 8-K | 1.01,9.01 | 0000950170-22-004311 | 001-40288 | 22760080 | 34 | 302521 | 1 | 1 |
| 2022-03-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-020082 | 4676 | ||||||
| 2022-03-10 | S-8 | S-8 | 0001193125-22-072001 | 333-263427 | 22729501 | 33 | 60936 | |||
| 2022-03-10 | 10-K | 10-K | 0000950170-22-003369 | 001-40288 | 22729257 | 34 | 12728631 | 1 | 1 | |
| 2022-03-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-003356 | 001-40288 | 22729093 | 34 | 398647 | 1 | 1 |
| 2022-02-14 | SC 13G/A | schedule13g.htm | 0000929638-22-000480 | 005-92462 | 22630197 | 34 | 153936 | |||
| 2022-02-09 | SC 13G | SC 13G | 0001193125-22-032746 | 005-92462 | 22607698 | 34 | 37529 | |||
| 2022-02-09 | SC 13G | SC 13G | 0001193125-22-032735 | 005-92462 | 22607623 | 34 | 66547 | |||
| 2022-02-09 | SC 13G | SC 13G | 0001193125-22-032725 | 005-92462 | 22607568 | 34 | 62125 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006581 | 5647 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006579 | 5613 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006577 | 5607 | ||||||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-006576 | 5645 | ||||||
| 2021-11-09 | 10-Q | 10-Q | 0000950170-21-003753 | 001-40288 | 211392422 | 34 | 8562379 | 1 | 1 | |
| 2021-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003747 | 001-40288 | 211392255 | 34 | 393111 | 1 | 1 |
| 2021-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-059038 | 5539 | ||||||
| 2021-09-20 | 3 | FORM 3 SUBMISSION | 0001209191-21-056960 | 6135 | ||||||
| 2021-09-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-054492 | 7731 | ||||||
| 2021-08-20 | 8-K | 8-K | 5.02 | 0001193125-21-252071 | 001-40288 | 211191723 | 34 | 152509 | 1 | 1 |
| 2021-08-17 | 3 | FORM 3 SUBMISSION | 0001209191-21-052064 | 9144 | ||||||
| 2021-08-09 | 10-Q | 10-Q | 0001564590-21-042734 | 001-40288 | 211157491 | 34 | 7810342 | 1 | 1 | |
| 2021-08-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-042617 | 001-40288 | 211156436 | 34 | 440217 | 1 | 1 |
| 2021-08-06 | 8-K | 8-K | 5.02 | 0001193125-21-239304 | 001-40288 | 211153377 | 34 | 18492 | ||
| 2021-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-040998 | 5433 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-040994 | 8322 | ||||||
| 2021-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-040988 | 5431 | ||||||
| 2021-06-16 | 3 | FORM 3 SUBMISSION | 0001209191-21-040983 | 6054 | ||||||
| 2021-06-07 | 8-K | 8-K | 5.02 | 0001564590-21-031964 | 001-40288 | 21999825 | 34 | 30532 | ||
| 2021-05-10 | 10-Q | 10-Q | 0001564590-21-026062 | 001-40288 | 21907421 | 34 | 6172938 | 1 | ||
| 2021-05-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-026050 | 001-40288 | 21907250 | 34 | 233541 | ||
| 2021-04-09 | SC 13G | schedule13g.htm | 0000929638-21-000600 | 005-92462 | 21817897 | 34 | 168122 | |||
| 2021-04-09 | SC 13D | SC 13D | 0001193125-21-111505 | 005-92462 | 21817723 | 34 | 144665 | |||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024248 | 4825 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024242 | 11209 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024238 | 17247 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024234 | 13735 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024233 | 13927 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024231 | 4639 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024229 | 9643 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024226 | 4701 | ||||||
| 2021-04-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-024224 | 14347 | ||||||
| 2021-04-01 | 4 | FORM 4 | 0001567619-21-007374 | 20460 | ||||||
| 2021-03-30 | 3/A | FORM 3/A SUBMISSION | 0001209191-21-023612 | 10219 | ||||||
| 2021-03-30 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-21-100253 | 001-40288 | 21786556 | 34 | 183412 | ||
| 2021-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-023472 | 5263 | ||||||
| 2021-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-023466 | 5286 | ||||||
| 2021-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-023465 | 5255 | ||||||
| 2021-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-023463 | 5290 | ||||||
| 2021-03-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-023462 | 5255 | ||||||
| 2021-03-26 | S-8 | S-8 | 0001193125-21-096749 | 333-254794 | 21778478 | 33 | 86376 | |||
| 2021-03-26 | 424B4 | 424B4 | 0001193125-21-096741 | 333-253954 | 21778426 | 33 | 3735653 | |||
| 2021-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-03-25 16:00:00 | 9999999995-21-001140 | 333-253954 | 21774464 | 33 | 1687 | ||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023128 | 6556 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023127 | 11011 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023126 | 9267 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023125 | 7304 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023124 | 6981 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023122 | 7714 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023121 | 8142 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023120 | 6606 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023119 | 6985 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023118 | 6642 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023117 | 9477 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023114 | 6680 | ||||||
| 2021-03-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-023112 | 3507 | ||||||
| 2021-03-25 | 3 | FORM 3 | 0001567619-21-006965 | 14743 | ||||||
| 2021-03-24 | CERT | 8A_Cert_DSGN.pdf | 0001354457-21-000410 | 001-40288 | 21769155 | 34 | 197535 | |||
| 2021-03-24 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-001403 | 275500 | ||||||
| 2021-03-23 | 8-A12B | 8-A12B | 0001193125-21-091210 | 001-40288 | 21765006 | 34 | 13589 | |||
| 2021-03-23 | CORRESP | filename1.htm | 0001193125-21-091190 | 11581 | ||||||
| 2021-03-23 | CORRESP | filename1.htm | 0001193125-21-091180 | 9106 | ||||||
| 2021-03-22 | CORRESP | filename1.htm | 0001193125-21-088362 | 17974 | ||||||
| 2021-03-22 | S-1/A | S-1/A | 0001193125-21-088348 | 333-253954 | 21759802 | 33 | 4908085 | |||
| 2021-03-18 | UPLOAD | filename1.pdf | 0000000000-21-003281 | 44406 | ||||||
| 2021-03-16 | CORRESP | filename1.htm | 0001193125-21-082015 | 82969 | ||||||
| 2021-03-05 | CORRESP | filename1.htm | 0001193125-21-071686 | 35062 | ||||||
| 2021-03-05 | S-1 | S-1 | 0001193125-21-071667 | 333-253954 | 21719604 | 33 | 5678319 | |||
| 2021-02-23 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000959 | 276639 | ||||||
| 2021-02-23 | UPLOAD | filename1.pdf | 0000000000-21-002174 | 53396 | ||||||
| 2021-02-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001807120-21-000002 | 021-389403 | 21628276 | 33 | 11859 | ||
| 2021-01-26 | DRS | filename1.htm | 0000950123-21-000626 | 377-04103 | 21554999 | 33 | 5020374 | |||
| 2020-06-03 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001807120-20-000002 | 021-363353 | 20938289 | 33 | 10210 | ||
| 2020-03-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001807120-20-000001 | 021-363353 | 20731212 | 33 | 10115 |
One latest value per concept from companyfacts (199 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 64.04M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 114.34M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 26,100 | 2026-11-03 | S-3 | 2026-11-04 | 0001193125-26-447545 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 26,100 | 2026-11-03 | S-3 | 2026-11-04 | 0001193125-26-447545 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 300.00M | 2026-11-03 | S-3 | 2026-11-04 | 0001193125-26-447545 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-03 | S-3 | 2026-11-04 | 0001193125-26-447545 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-11-03 | S-3 | 2026-11-04 | 0001193125-26-447545 | |||
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 10.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 8,000 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-08 | 0000950170-22-015533 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 144,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 10.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 2.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 558.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 11.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 11.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 17.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | Assets | Assets | USD | 216.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 213.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 4,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 195.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 193.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-04-28 | 0001193125-26-187063 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 15.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 208.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 15.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 63.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 63.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 6,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -60.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 271,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | ConvertibleDebt | Convertible Debt | USD | 200,000 | 2019-02-28 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 500,000 | 2020-02-01 | 2020-02-29 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.08 | 2019-02-28 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 490,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 304,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-035910 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 175.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 1.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions | Security | 38 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 175.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 1.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Security | 63 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 212,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 67.87M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 546,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 31.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 11.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 3.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 67.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 546,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 241,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 500,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | DepositsAssetsCurrent | Deposits Assets, Current | USD | 47,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | Depreciation | Depreciation | USD | 444,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.93 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.24 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008500 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.93 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.19 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.02 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 1.72M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.025 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.029 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 3.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 20.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 16.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 13.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -14.66M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 25,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -38,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -181,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 474,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 1.07M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-09 | 0001564590-21-042734 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | USD | -115,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -201,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 144,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 1.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | InterestExpenseRelatedParty | Interest Expense, Related Party | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 24,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 1.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 6.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | InvestmentsFairValueDisclosure | Investments, Fair Value Disclosure | USD | 206.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 2.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 561,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 898,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 663,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-14 | 0000950170-23-007869 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 663,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033492 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 952,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 925,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 218,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 479,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | Liabilities | Liabilities | USD | 14.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 216.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 12.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 193.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 38.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 7.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -47.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -58.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 64.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -64.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 700,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 2.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 655,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 1.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 2.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 6,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0000950170-25-035910 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.107 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 717,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | OtherAssets | Other Assets | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 7,000 | 2021-12-31 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021885 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -2.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 145,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 9.75M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123349 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 4,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033492 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 12,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 427,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033492 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 94.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 36,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 5.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 3.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 254.27M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-14 | 0000950170-23-007869 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 37.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 124.71M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-14 | 0000950170-23-007869 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 35,000 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003753 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 102.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 39,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033492 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 445,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -58.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 3.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 573,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Expenses from Transactions with Related Party | USD | 259,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019714 |
| us-gaap | RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party | USD | 135,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019714 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 47.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -355.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 226,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 |
| us-gaap | Revenues | Revenues | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 11.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | USD/shares | 13.5 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-14 | 0000950170-23-007869 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.85 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.043 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 21.67B | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 6.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 8.12 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 300,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 167,584 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 4.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.29 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 53.72B | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 17.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 7.31 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 52.86B | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 13.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 6.51 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 4.62 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 7.08 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 9.79 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 202.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.613 | 2021-03-01 | 2021-03-31 | 2022 | FY | 10-K | 2023-03-14 | 0000950170-23-007869 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 184,916 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 170.07M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-14 | 0000950170-23-007869 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 464,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 37.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 445,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 45.36M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003753 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-10 | 0000950170-22-003369 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 2.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 523,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-098491 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 87,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033492 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 62.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 55.51M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008500 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 62.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-447258 |